Related Experiment Video
Updated: May 10, 2026
07:34
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
Published on: March 1, 2019
Epigenetic mechanisms in cerebral ischemia
Sophie Schweizer1, Andreas Meisel, Stefanie Märschenz
1Department of Neurology and Experimental Neurology, Center of Stroke Research Berlin, Charité University Medicine, Charitéplatz 1, Berlin, Germany.
Summary
Epigenetic modifications, like histone deacetylation inhibition, show promise for treating ischemic stroke. These approaches can influence pathways involved in stroke damage and regeneration, offering new therapeutic avenues.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Ischemic stroke treatment efficacy remains a significant challenge, with limited options for improving functional recovery.
- Advances in understanding stroke etiology have been made, but therapeutic breakthroughs are still needed.
- Epigenetics has revolutionized the understanding of gene regulation, offering new perspectives on neurological diseases.
Purpose of the Study:
- To review the role of epigenetic mechanisms in ischemic stroke.
- To discuss how epigenetic modifications influence pathways of damage, protection, and regeneration in ischemic stroke.
- To highlight the therapeutic potential of epigenetic manipulation for ischemic stroke.
Main Methods:
- Review of existing literature on epigenetics and ischemic stroke.
- Discussion of epigenetic modifiers, including histone modifications and DNA methylation.
- Focus on findings from animal models, particularly the effects of histone deacetylase inhibitors (HDACi).
Main Results:
- Epigenetic modifiers can influence multiple pathways in ischemic stroke development.
- Beneficial effects include reduced cell death, suppressed inflammation, enhanced blood flow, and stimulated repair and plasticity.
- Pharmacological inhibition of histone deacetylation (using HDACi) shows significant therapeutic potential, even with late administration in animal models.
Conclusions:
- Epigenetic mechanisms represent a promising target for novel ischemic stroke therapies.
- Histone deacetylase inhibitors demonstrate notable potential for improving outcomes in preclinical models.
- Further research into epigenetic strategies could lead to improved functional recovery after stroke.
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.